当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:225.24亿  总市值:301.74亿
流通股本:7.66亿   总股本:10.27亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,577,488,871.511,559,876,252.73836,531,206.522,711,136,293.87
  收到的税费返还32,819,697.1332,819,697.13-35,324,766.64
  收到其他与经营活动有关的现金78,414,007.2854,879,628.394,634,382.4194,822,421.53
  经营活动现金流入小计2,688,722,575.921,647,575,578.25841,165,588.932,841,283,482.04
  购买商品、接受劳务支付的现金1,233,849,897.27790,403,738.4394,081,798.571,787,943,409.49
  支付给职工以及为职工支付的现金1,033,836,711.19730,805,430.16314,545,623.441,206,151,226.86
  支付的各项税费127,711,928.9179,334,795.3929,296,607.61111,872,785.91
  支付其他与经营活动有关的现金127,779,443.97115,593,835.1745,392,324.32254,883,792.1
  经营活动现金流出小计2,523,177,981.341,716,137,799.12783,316,353.943,360,851,214.36
  经营活动产生的现金流量净额165,544,594.58-68,562,220.8757,849,234.99-519,567,732.32
二、投资活动产生的现金流量:
  收回投资收到的现金5,482,500,0002,063,500,000651,000,0002,270,000,000
  取得投资收益收到的现金15,506,796.127,073,303.092,550,493.159,538,557.03
  处置固定资产、无形资产和其他长期资产收回的现金净额138,757138,757-13,016,642.5
  收到的其他与投资活动有关的现金24,341,101.716,169,814.747,392,058.7832,707,349.67
  投资活动现金流入小计5,522,486,654.822,086,881,874.83660,942,551.932,325,262,549.2
  购建固定资产、无形资产和其他长期资产支付的现金528,623,420.59337,187,490.98251,907,576.74768,298,592.7
  投资支付的现金6,712,510,409.943,179,148,736.73950,400,0023,116,756,642.41
  支付其他与投资活动有关的现金8,911,066.448,911,066.44-20,918,197.31
  投资活动现金流出小计7,250,044,896.973,525,247,294.151,202,307,578.743,905,973,432.42
  投资活动产生的现金流量净额-1,727,558,242.15-1,438,365,419.32-541,365,026.81-1,580,710,883.22
三、筹资活动产生的现金流量:
  吸收投资收到的现金---940,183,277.12
  其中:子公司吸收少数股东投资收到的现金---600,000
  取得借款收到的现金1,674,488,989.361,542,421,530.951,421,047,188.743,578,540,240.08
  发行债券收到的现金2,000,000,0001,000,000,0001,000,000,000-
  收到其他与筹资活动有关的现金3,192,579.131,668,002.54-246,000,000
  筹资活动现金流入小计3,677,681,568.492,544,089,533.492,421,047,188.744,764,723,517.2
  偿还债务支付的现金1,031,495,558.3790,760,650.61582,300,0002,397,592,040.59
  分配股利、利润或偿付利息支付的现金90,446,726.5360,485,075.2728,011,611.3594,328,861.04
  支付其他与筹资活动有关的现金93,540,049.9748,430,341.5618,386,914.9843,496,873.16
  筹资活动现金流出小计1,215,482,334.8899,676,067.44628,698,526.332,535,417,774.79
  筹资活动产生的现金流量净额2,462,199,233.691,644,413,466.051,792,348,662.412,229,305,742.41
四、汇率变动对现金及现金等价物的影响-29,474,316.51-25,542,687.74-12,144,143-21,706,525.95
五、现金及现金等价物净增加额870,711,269.61111,943,138.121,296,688,727.59107,320,600.92
  加:期初现金及现金等价物余额2,593,999,709.742,593,999,709.742,593,999,709.742,486,679,108.82
  期末现金及现金等价物余额3,464,710,979.352,705,942,847.863,890,688,437.332,593,999,709.74
补充资料:
  净利润--40,823,699.21--1,009,393,410.45
  资产减值准备-4,109,940.68-98,098,076.08
  固定资产和投资性房地产折旧-120,761,561.07-243,515,843.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-120,761,561.07-243,515,843.96
  无形资产摊销-17,897,176.61-35,257,393.82
  长期待摊费用摊销-3,134,962.73-5,444,464.77
  处置固定资产、无形资产和其他长期资产的损失--48,467,787.3--35,259,378.72
  固定资产报废损失-237,088.29-176,171.61
  公允价值变动损失--25,736,499.34--57,210,254.39
  财务费用-73,849,509.17-67,894,071.23
  投资损失--108,091,473.65-106,416,782.78
  递延所得税-1,972,853.59--1,263,252.01
  其中:递延所得税资产减少-1,972,853.59--1,263,252.01
  存货的减少--57,213,889.81--53,110,382.81
  经营性应收项目的减少--282,173,865.23-105,159,472.72
  经营性应付项目的增加-2,753,318.45--128,073,222.72
  其他-122,614,377.5-72,098,306.74
  现金的期末余额-2,705,942,847.86-2,593,999,709.74
  减:现金的期初余额-2,593,999,709.74-2,486,679,108.82
  现金及现金等价物的净增加额-111,943,138.12-107,320,600.92
公告日期2026-10-302026-08-272026-04-282026-03-14
审计意见(境内)标准无保留意见
TOP↑